Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON PANACEA BIOTECH BIOCON /
PANACEA BIOTECH
 
P/E (TTM) x 33.3 0.8 4,300.8% View Chart
P/BV x 4.1 1.0 421.1% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 BIOCON    PANACEA BIOTECH
EQUITY SHARE DATA
    BIOCON
Mar-22
PANACEA BIOTECH
Mar-22
BIOCON /
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs424454 93.5%   
Low Rs315148 212.8%   
Sales per share (Unadj.) Rs68.2108.0 63.1%  
Earnings per share (Unadj.) Rs8.2176.0 4.6%  
Cash flow per share (Unadj.) Rs14.9183.1 8.2%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %0.10-  
Book value per share (Unadj.) Rs68.5138.6 49.5%  
Shares outstanding (eoy) m1,200.6061.25 1,960.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.42.8 194.5%   
Avg P/E ratio x45.31.7 2,652.0%  
P/CF ratio (eoy) x24.71.6 1,506.2%  
Price / Book Value ratio x5.42.2 248.3%  
Dividend payout %6.10-   
Avg Mkt Cap Rs m443,62218,427 2,407.4%   
No. of employees `000NANA-   
Total wages/salary Rs m18,8011,829 1,027.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m81,8406,612 1,237.7%  
Other income Rs m6,891110 6,282.2%   
Total revenues Rs m88,7316,722 1,320.0%   
Gross profit Rs m13,82716,623 83.2%  
Depreciation Rs m8,142437 1,864.8%   
Interest Rs m6761,808 37.4%   
Profit before tax Rs m11,90014,488 82.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,1153,709 57.0%   
Profit after tax Rs m9,78510,779 90.8%  
Gross profit margin %16.9251.4 6.7%  
Effective tax rate %17.825.6 69.4%   
Net profit margin %12.0163.0 7.3%  
BALANCE SHEET DATA
Current assets Rs m83,82310,406 805.6%   
Current liabilities Rs m38,2808,028 476.9%   
Net working cap to sales %55.636.0 154.8%  
Current ratio x2.21.3 168.9%  
Inventory Days Days10161 165.4%  
Debtors Days Days9273 126.3%  
Net fixed assets Rs m117,1847,118 1,646.3%   
Share capital Rs m6,00361 9,800.8%   
"Free" reserves Rs m76,2818,427 905.2%   
Net worth Rs m82,2848,488 969.4%   
Long term debt Rs m39,985341 11,724.8%   
Total assets Rs m201,00717,523 1,147.1%  
Interest coverage x18.69.0 206.4%   
Debt to equity ratio x0.50 1,209.5%  
Sales to assets ratio x0.40.4 107.9%   
Return on assets %5.271.8 7.2%  
Return on equity %11.9127.0 9.4%  
Return on capital %10.3184.6 5.6%  
Exports to sales %018.2 0.0%   
Imports to sales %7.822.4 34.6%   
Exports (fob) Rs mNA1,205 0.0%   
Imports (cif) Rs m6,3601,484 428.5%   
Fx inflow Rs m8,8851,236 719.1%   
Fx outflow Rs m6,3601,735 366.6%   
Net fx Rs m2,525-499 -505.6%   
CASH FLOW
From Operations Rs m11,766-1,084 -1,085.1%  
From Investments Rs m-16,99112,826 -132.5%  
From Financial Activity Rs m2,421-11,759 -20.6%  
Net Cashflow Rs m-2,433-17 14,071.7%  

Share Holding

Indian Promoters % 39.7 73.6 54.0%  
Foreign collaborators % 20.9 0.0 -  
Indian inst/Mut Fund % 24.0 0.0 -  
FIIs % 16.3 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 26.4 149.0%  
Shareholders   341,016 49,896 683.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    AUROBINDO PHARMA    LUPIN    


More on Biocon vs Panacea Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Biocon vs Panacea Biotech Share Price Performance

Period Biocon Panacea Biotech S&P BSE HEALTHCARE
1-Day -1.87% -3.88% -0.46%
1-Month -7.46% 2.10% 0.65%
1-Year -22.76% -53.21% -13.70%
3-Year CAGR 8.02% -2.71% 20.93%
5-Year CAGR -3.68% -8.78% 10.98%

* Compound Annual Growth Rate

Here are more details on the Biocon share price and the Panacea Biotech share price.

Moving on to shareholding structures...

The promoters of Biocon hold a 60.6% stake in the company. In case of Panacea Biotech the stake stands at 73.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Biocon and the shareholding pattern of Panacea Biotech.

Finally, a word on dividends...

In the most recent financial year, Biocon paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 6.1%.

Panacea Biotech paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Biocon, and the dividend history of Panacea Biotech.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

5 Reasons Why Sensex Plunged 1,021 Points Today(Closing)

After opening the day on a negative note, Indian share markets extended losses as the session progressed and ended deep in the red.